Status:
COMPLETED
Blood Transfusions in Thalassemia Patients, Complications and Adverse Effects
Lead Sponsor:
HaEmek Medical Center, Israel
Conditions:
Thalassemia
Sickle Cell Anemia
Eligibility:
All Genders
1-50 years
Brief Summary
Patients suffering from Thalassemia or another hemoglobinopathies required regular blood transfusions. The complications and adverse effects of blood transfusions can be classified as immediate and la...
Detailed Description
About 100 patients aged several months to 50 years are treated in the Pediatric Hematology Unit, most of those patients receive blood transfusions monthly. The adverse reactions were routinely recorde...
Eligibility Criteria
Inclusion
- Patients receiving blood transfusions due to chronic hematologic disorders
Exclusion
- Not applicable
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2010
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00971880
Start Date
May 1 2009
End Date
November 1 2010
Last Update
August 26 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric Hematology Unit and Pediatric Dpt B - HaEmek Medical Center
Afula, Israel, 18101